CORE
CO
nnecting
RE
positories
Services
Services overview
Explore all CORE services
Access to raw data
API
Dataset
FastSync
Content discovery
Recommender
Discovery
OAI identifiers
OAI Resolver
Managing content
Dashboard
Bespoke contracts
Consultancy services
Support us
Support us
Membership
Sponsorship
Research partnership
About
About
About us
Our mission
Team
Blog
FAQs
Contact us
Community governance
Governance
Advisory Board
Board of supporters
Research network
Innovations
Our research
Labs
First-line sequential high-dose VIP chemotherapy with autologous transplantation for patients with primary mediastinal nonseminomatous germ cell tumours: a prospective trial
Authors
B Metzner
C Bokemeyer
+48 more
C Bokemeyer
C Bokemeyer
C Bokemeyer
C Kollmannsberger
CD Wright
CJ Logothetis
CR Nichols
CR Nichols
CR Nichols
CR Nichols
CR Nichols
D Josefsen
DH Collins
EL Kaplan
EM Dulmet
FG Delgado
GC Toner
GJ Bosl
H-J Schmoll
I Boehlke
J T Hartmann
J Vuky
JT Hartmann
JT Hartmann
JT Hartmann
JT Hartmann
JT Hartmann
JT Hartmann
JT Hartmann
JT Hartmann
KN Ganjoo
L Kanz
M Hidalgo
M Thomas
MJ Harding
N Schleucher
O Rick
O Rick
PH Kay
PJ Loehrer Sr
R Birch
RJ Motzer
RJ Motzer
RJ Motzer
RM Bukowski
SB Saxman
TM Ulbright
WJ Childs
Publication date
Publisher
Nature Publishing Group
Doi
View
on
PubMed
Abstract
Abstract is not available.
Similar works
Full text
Open in the Core reader
Download PDF
Available Versions
Crossref
See this paper in CORE
Go to the repository landing page
Download from data provider
Last time updated on 06/12/2019